Page last updated: 2024-08-26

bosentan anhydrous and phorbol 12,13-dibutyrate

bosentan anhydrous has been researched along with phorbol 12,13-dibutyrate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Babinet, C; Briand, P; Colucci-Guyon, E; Federici, P; Friedlander, G; Henrion, D; Levy, BI; Terzi, F1

Other Studies

1 other study(ies) available for bosentan anhydrous and phorbol 12,13-dibutyrate

ArticleYear
Reduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide imbalance.
    The Journal of clinical investigation, 1997, Sep-15, Volume: 100, Issue:6

    Topics: Acetylcholine; Animals; Antihypertensive Agents; Blotting, Northern; Bosentan; Creatinine; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Immunohistochemistry; In Vitro Techniques; Indomethacin; Kidney; Mice; Mice, Knockout; Mice, Mutant Strains; Muscle, Smooth, Vascular; NADPH Dehydrogenase; Nephrectomy; Nitric Oxide; Nitroarginine; Nitroprusside; Phorbol 12,13-Dibutyrate; RNA, Messenger; Sulfonamides; Vasoconstrictor Agents; Vasodilator Agents; Vimentin

1997